BUNGE GLOBAL SA (BG)

CH1300646267 - Common Stock

93.06  +1.39 (+1.52%)

After market: 93.06 0 (0%)

Fundamental Rating

6

BG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 91 industry peers in the Food Products industry. BG scores excellent on profitability, but there are some minor concerns on its financial health. BG has a bad growth rate and is valued cheaply. These ratings could make BG a good candidate for value investing.



7

1. Profitability

1.1 Basic Checks

In the past year BG was profitable.
BG had a positive operating cash flow in the past year.
Of the past 5 years BG 4 years were profitable.
BG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

BG's Return On Assets of 8.84% is amongst the best of the industry. BG outperforms 85.56% of its industry peers.
BG has a Return On Equity of 18.99%. This is amongst the best in the industry. BG outperforms 88.89% of its industry peers.
BG has a Return On Invested Capital of 13.18%. This is amongst the best in the industry. BG outperforms 92.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BG is above the industry average of 7.75%.
The 3 year average ROIC (12.48%) for BG is below the current ROIC(13.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.84%
ROE 18.99%
ROIC 13.18%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.03%
ROE(5y)11.84%
ROIC(3y)12.48%
ROIC(5y)10.08%

1.3 Margins

The Profit Margin of BG (3.77%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BG has grown nicely.
BG has a Operating Margin of 5.21%. This is in the better half of the industry: BG outperforms 64.44% of its industry peers.
In the last couple of years the Operating Margin of BG has grown nicely.
BG has a Gross Margin of 8.09%. This is in the lower half of the industry: BG underperforms 72.22% of its industry peers.
In the last couple of years the Gross Margin of BG has grown nicely.
Industry RankSector Rank
OM 5.21%
PM (TTM) 3.77%
GM 8.09%
OM growth 3Y15.11%
OM growth 5Y23.32%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.55%
GM growth 5Y10.44%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BG is creating some value.
Compared to 1 year ago, BG has more shares outstanding
Compared to 5 years ago, BG has more shares outstanding
The debt/assets ratio for BG is higher compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of BG is 2.23, which is a good value as it means it would take BG, 2.23 years of fcf income to pay off all of its debts.
BG has a better Debt to FCF ratio (2.23) than 82.22% of its industry peers.
BG has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
BG's Debt to Equity ratio of 0.41 is in line compared to the rest of the industry. BG outperforms 53.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 2.23
Altman-Z N/A
ROIC/WACC1.73
WACC7.61%

2.3 Liquidity

BG has a Current Ratio of 2.13. This indicates that BG is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.13, BG is doing good in the industry, outperforming 65.56% of the companies in the same industry.
A Quick Ratio of 1.20 indicates that BG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.20, BG is doing good in the industry, outperforming 72.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.2

3

3. Growth

3.1 Past

The earnings per share for BG have decreased by -1.80% in the last year.
Measured over the past years, BG shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.38% on average per year.
Looking at the last year, BG shows a very negative growth in Revenue. The Revenue has decreased by -11.44% in the last year.
BG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)-1.8%
EPS 3Y25.64%
EPS 5Y55.38%
EPS growth Q2Q14.2%
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Revenue growth Q2Q-10.35%

3.2 Future

Based on estimates for the next years, BG will show a decrease in Earnings Per Share. The EPS will decrease by -5.43% on average per year.
The Revenue is expected to grow by 0.78% on average over the next years.
EPS Next Y-13.4%
EPS Next 2Y-5.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.34%
Revenue Next 2Y0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.81, which indicates a rather cheap valuation of BG.
Based on the Price/Earnings ratio, BG is valued cheaper than 96.67% of the companies in the same industry.
BG is valuated cheaply when we compare the Price/Earnings ratio to 26.00, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.15 indicates a reasonable valuation of BG.
Based on the Price/Forward Earnings ratio, BG is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BG to the average of the S&P500 Index (21.38), we can say BG is valued rather cheaply.
Industry RankSector Rank
PE 6.81
Fwd PE 8.15

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BG is valued cheaper than 90.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BG is valued cheaper than 91.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.19
EV/EBITDA 4.17

4.3 Compensation for Growth

The decent profitability rating of BG may justify a higher PE ratio.
BG's earnings are expected to decrease with -5.43% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-5.43%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.92%, BG has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.53, BG pays a bit more dividend than its industry peers.
BG's Dividend Yield is comparable with the S&P500 average which is at 2.48.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

The dividend of BG has a limited annual growth rate of 5.08%.
BG has paid a dividend for at least 10 years, which is a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)5.08%
Div Incr Years3
Div Non Decr Years20

5.3 Sustainability

BG pays out 17.08% of its income as dividend. This is a sustainable payout ratio.
DP17.08%
EPS Next 2Y-5.43%
EPS Next 3YN/A

BUNGE GLOBAL SA

NYSE:BG (2/21/2024, 7:04:00 PM)

After market: 93.06 0 (0%)

93.06

+1.39 (+1.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap13.52B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 6.81
Fwd PE 8.15
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.12
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 18.99%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.21%
PM (TTM) 3.77%
GM 8.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.13
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1.8%
EPS 3Y25.64%
EPS 5Y
EPS growth Q2Q
EPS Next Y-13.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y